New York City-based VSS Capital Partners has announced a new strategic investment in Center for Rheumatology (CFR). No terms of the deal were disclosed. Stout served as exclusive financial advisor to CFR and McDermott Will & Emery LLP served as counsel to CFR. Waller Law served as counsel for VSS.
Located in Los Angeles, California, Center for Rheumatology specializes in treating arthritis, rheumatoid arthritis, celiac disease, psoriasis, lupus, gout and certain myofascial conditions.
VSS is a private investment firm that invests in the healthcare, information, business services and education industries. The firm provides capital for growth financing, recapitalizations, strategic acquisitions and buyouts to lower middle-market companies and management teams with the goal of building companies organically as well as through an acquisition program.
The investment firm has been relatively active over the past several years. In 2021, VSS purchased
Ambulatory Management Solutions, which provides turnkey anesthesia and administrative support services for in-office and ambulatory-based surgical procedures to physician practices across various specialties that are completing surgical procedures for lower-risk patients in an office setting. And then back in 2020, it acquired Podiatry Growth Partners, a podiatry practice management platform that operates a national network of regionally branded podiatry clinics.
Since partnering with VSS, Podiatry Growth Partners has announced six deals in the physician market, expanding the reach of its network. With the addition of Center of Rheumatology in its portfolio, it will give VSS the opportunity to reach into new markets. Keep an eye on this partnership in the future.
